Focal nodular hyperplasia of the liver: Pathological analysis of 11 cases

Hepatobiliary and Pancreatic Diseases International

Volumn 3, Issue 2, 2004, Pages 199-203

  Pan, Yi ^a   Wang, Zhao Ming ^a   Mou, Ling Jun ^a   Teng, Xiao Dong ^a   Zheng, Zhou Jun ^a   Ying, Li Xiong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hepatic focal nodular hyperplasia; Pathological diagnosis; Pathology

Indexed keywords

ALPHA FETOPROTEIN; EOSIN; HEMATOXYLIN;

ADENOMA; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; MICROSCOPY; NODULAR HYPERPLASIA; RETROSPECTIVE STUDY; SCAR FORMATION; STAINING; TELANGIECTASIA;

ADULT; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 2442636561     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Edmondson HA. Tumors of the liver and intrahepatic bile ducts. In: atlas of tumor pathology, fascicle 25. Washington: Armed Forces Institute of Pathology;1958.
2. Nguyen BN, Flejou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999;23:1441-1454.
3. De Carlis L, Pirotta V, Rondinara GF, Sansalone CV, Colella G, Maione G, et al. Hepatic adenoma and focal nodular hyperplasia: diagnosis and criteria for treatment. Liver Transpl Surg 1997;3:160-165.
4. Ganne-Carrie N, Chatang C, Chapel F, Munz C, Pateron D, Sibony M, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 1996;23: 1112-1118.
5. Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, et al. Benign liver tumors: differential diagnosis and indications for surgery. Word J Surg 1997;21:983-990.
6. Kimura H, Nakajima T, Kagawa K, Deguchi T, Kakusui M, Katagishi T, et al. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. Liver 1998;18:14-19.
7. Roskams T, De Vos R, Desmet V. 'Undifferentiated progenitor cells' in focal nodular hyperplasia of the liver. Histopathology 1996;28:291-299.
8. Knowles DM, Wolff M. Focal nodular hyperplasia of the liver: a clinicopathologic study and review of the literature. Hum Pathol 1976;7:533-545.
9. Wanless IR, Wawdsley C, Adams R. On the pathogenesis of Focal Nodular Hyperplasia of the liver. Hepatology 1985;5: 1194-1200.
10. Nakamuta M, Ohashi M, Fukutomi T, Tanabe Y, Hiroshige K, Nakashima O, et al. Oral contraceptive-dependent growth of focal nodular hyperplasia. J Gastroenterol Hepatol 1994;9: 521-523.
11. D'halluin V, Vilgrain V, Pelletier G, Rocher L, Belghiti J, Erlinger S, et al. Natural history of focal nodular hyperplasia. A retrospective study of 44 cases. Gastroenterol Clin Biol 2001; 25:1008-1010.
12. Paradis V, Bieche I, Dargere D, Laurendeau I, Nectoux J, Degott C, et al. A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. Gastroenterology 2003;124:651-659.
13. Hytiroglou P, Theise ND, Schwartz M, Mor E, Miller C, Thung SN. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature. Hepatology 1995;21:703-708.
14. Brunt EM. Benign tumors of the liver. Clin Liver Dis 2001;5: 1-15.
15. Chen LK, Chang FC, Lai CR, Luo JC, Tsai ST, Hwang SJ. Huge adenomatous hyperplasia of the liver. J Clin Gastroenterol 2002;34:272-274.
16. Orsatti G, Theise ND, Thung SN, Paronetto F. DNA image cytometric analysis of macroregenerative nodules (adenomatous hyperplasia) of the liver: evidence in support of their preneoplastic nature. Hepatology 1993;17:621-627.
17. Thomas R, Kirsten F, Klaus G, Benno R. Liver tumours in women on oral contraceptives. Lancet 1994;344:1568-1569.
18. Mergo PJ, Ros PR. Benign lesions of the liver. Radiol Clin North Am 1998;36:319-331.
19. Fulcher AS, Sterling RK. Hepatic neoplasms: computed tomography and magnetic resonance features. J Clin Gastroenterol 2002;34:463-471.
20. Zhao ZC, Zheng SS, Wan YL, Jia CK, Xie HY. The molecular mechanism underlying angiogenesis in hepatocellular carcinoma: the imbalance activation of signaling pathways. Hepatobiliary Pancreat Dis Int 2003;2:529-536.
21. Zhou XD. Recurrence and metastasis of hepatocellular carcinoma: progress and prospects. Hepatobiliary Pancreat Dis Int 2002;1:35-41.
22. Zhou DH, Feng YZ, Zhao WH, Ma ZM. Thirty-one patients with primary hepatocellular carcinoma survived for more than 5 years after hepatectomy. Hepatobiliary Pancreat Dis Int 2002;1:191-193.
23. Cao ZX, Chen XP, Wu ZD. Changes of immune function in patients with liver cirrhosis after splenectomy combined with resection of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2003;2:562-565.
24. Le Bail B, Bernard PH, Carles J, Balabaud C, Bioulac-Sage P. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J Hepatol 1997;27: 835-842.
25. Rui JA, Wang SB, Chen SG, Zhou L, Wei X, Han K, et al. Serial therapies oriented by surgery for large primary liver carcinoma. Hepatobiliary Pancreat Dis Int 2002;1:411-415
26. Imai T, Yokoi H, Noguchi H, Kawarada Y, Miaumoto R. Fibrolamellar carcinoma of the liver: a case report. Gastroenterol Jpn 1991;26:382-389.
27. Saab S, Yao F. Fibrolamellar hepatocellular carcinoma. Case reports and a review of the literature. Dig Dis Sci 1996;41: 1981-1985.
28. Kaczynski J, Gustavsson B, Hansson G, Wallerstedt S. Fibrolamellar hepatic carcinoma in an area with a low incidence of primary liver cancer: a retrospective study. Eur J Surg 1996;162: 367-371.
29. Perez-Guillermo M, Masgrau NA, Garcia-Solano J, Sola-Perez J, de Agustin Y, de Agustin P. Cytologic aspect of fibrolamellar hepatocellular carcinoma in fine-needle aspirates. Diagn Cytopathol 1999;21:180-187.
30. Orsatti G, Hyritoglou P, Thung SN, Ishak KG, Paronetto F. Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: a role for transforming growth factor beta. Liver 1997;12:152-156.